Protherics PLC
Notification of Major Interest in Shares
London, UK; Brentwood, TN, US; 18 June 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that, on 18 June 2007, a notification of interest in
the ordinary share capital of the Company was received from INVESCO plc in
accordance with the Transparency Obligations Directive. Details of the interest
are as follows:
2. Reason for the notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights: ( X )
An acquisition or disposal of financial instruments which may result ( )
in the acquisition of shares already issued to which voting rights are
attached:
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
2. Full name of person(s) subject to the notification obligation:
INVESCO plc
3. Full name of person(s) subject to the notification obligation:
4. Full name of shareholder(s) (if different from 3.):
12 June 2007
5. Date of the transaction and date on which the threshold is crossed or reached
if different):
18 June 2007
6. Date on which issuer notified:
10%, 11%
7. Threshold(s) that is/are crossed or reached:
8. Notified details:
A: Voting rights attached to shares
Class/type of shares Situation previous to
the Triggering
If possible using the transaction
ISIN CODE
Number of shares Number of voting Rights
Ordinary 2p Shares 35,740,354 35,740,354
(GB0007029209)
Resulting situation after the triggering transaction
Class/type of shares Number of shares Number of voting rights % of voting rights
If possible using
the ISIN CODE
Direct Direct Indirect Direct Indirect
Ordinary 2p Shares 37,361,912 37,361,912 11.01%
(GB0007029209)
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Date Exercise/Conversion Number of voting % of voting
financial Period/ Date rights that may be rights
instrument acquired if the
instrument is
exercised/
converted.
Total (A+B)
Number of voting rights % of voting rights
37,361,912 11.01%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
JP Morgan Chase - 7,792,308
Citibank - 29,454,292
Northern Trust Company (London) - 115,312
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
Ends
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
Protherics PLC announces Holding(s) in Company
| Source: Protherics PLC
Cheshire, UK--(Marketwire - June 18, 2007) -